- Details
- The Testicular Cancer Survivorship Clinic, lead by Adult Nurse Practitioner, Mary Dunn is designed to help patients transition from testicular cancer treatment to testicular cancer survivorship. The Testicular Cancer Survivorship Clinic was established in 2008, at the University of North Carolina. Patients who have completed definitive therapy for testicular cancer are transitioned into the clinic...
|
- Details
- Unequivocal clinical progression (UPC), a worsening of clinical status with or without radiographic progression represents a distinct mode of disease progression in metastatic prostate cancer. It is prognostic and associated with inferior overall survival and post-progression survival. In this conversation with Alicia Morgans, MD, MPH, Arpit Rao, MD highlights rigorous data set from the phase III...
|
- Details
- Real-world data on the use, survival impacts and efficacy of life-prolonging therapies for metastatic castration-resistant prostate cancer (mCRPC) are limited. In this conversation with Alicia Morgans, MD, MPH, Celestia Higano, MD highlights the publication Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in...
|
- Details
- Dena Battle from KCCure, a kidney cancer patient advocacy organization, joins Jaime Landman and Monty Pal to dispel common myths regarding the diagnosis and treatment of kidney cancer being observed in patient communities and to speak about what is driving this misinformation. Among the factors are evolving data, practice-changing data since first diagnoses, the lack of consensus where there isn’t...
|
- Details
- Drs Alicia Morgans and Charles Ryan review advancements in the treatment in prostate cancer from 2020. Dr. Ryan first reviews the Phase 3 HERO study, Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (ClinicalTrials.gov Identifier: NCT03085095), comparing relugolix, an oral gonadotropin-releasing hormone antagonist, to leuprolide in a 2:1 randomization which led to a very...
|
- Details
- Underinsured patients face significant barriers in accessing high‐quality care. “Access Denied: The Relationship Between Patient Insurance Status and Access to High‐volume Hospitals” studies the evidence of whether access to high‐volume surgical care is mediated by disparities in health insurance coverage. Quoc-Dien Trinh, an author of the study, joins Alicia Morgans to discuss his involvement in...
|
- Details
- Management decisions at presentation are critical for survival— a talk by Curtis A Pettaway, MD. Although primary urethral carcinoma (UC) is rare, with an incidence of 4.3 per million in men and 1.5 per million in women, recurrence is associated with distant metastases. Therefore, physicians will want to be alert to the possibility of UC when, for example, the patient has a urethral protrusion. Th...
|
- Details
- Studies have historically underrepresented Black and non-White prostate cancer patients limiting our understanding of the disparities in the diagnosis and prognosis of prostate cancer among these populations. Brandon Mahal, MD, joins Charles Ryan, MD, to discuss what he reported in this New England Journal of Medicine paper titled "Racial Differences in Genomic Profiling of Prostate Cancer." Biogr...
|
- Details
- An estimated 1.4 million adults identify as transgender in the United States. This number may be higher due to the lack of national population-based surveys measuring gender identity. Diane Newman welcomes Laura Douglass to discuss the role of the urologist in the care of transgender patients, and specifically the urologist's role in providing gender-affirming surgery. Biographies: Laura Douglass,...
|
- Details
- Andrea Necchi, MD, and Philippe Spiess, MD, MS, FRCS(C), FACS, join Alicia Morgans, MD, MPH, to discuss the new international effort to develop a Global Society of Rare Genitourinary (GU) Cancers. The Global Society of Rare Genitourinary Tumors (GSRGT) will have both an educational and research mission to promote evidence-based diagnostic and treatment standards across the world through conference...
|
